Alimentiv Announces Acquisition of McDougall Scientific Ltd.

For Immediate Release:

London, ON, CANADA, Release: March 2, 2021 – Alimentiv Health Trust, the parent company of Alimentiv, Inc. (formerly Robarts Clinical Trials), a specialized global gastrointestinal (GI) contract research organization (CRO), announced today the acquisition of Alimentiv Statistics Ltd. a niche CRO specializing in statistical analysis, top-tier data management, reporting, and clinical trial design.

The acquisition of Alimentiv Statistics delivers on the purpose of the Alimentiv Health Trust to build enduring organizations that prioritize investment in Health Research. “Alimentiv Statistics has for 40 years prioritized excellence in science through delivery of high quality statistical and data management services. We are thrilled to invite the Alimentiv organization into the Alimentiv family of companies and are eager to leverage our complementary capabilities to provide an enhanced level of services to our sponsors,” said Jeff Smith, CEO, Alimentiv, Inc.

John Amrhein, Vice President of Alimentiv Statistics who will assume additional responsibilities as Managing Director following the acquisition said, “The expertise of Alimentiv and Alimentiv Statistics are well aligned to enhance both the scope and depth of service offerings to the clients of both companies. Our shared values, emphasis on quality, and complementary corporate culture inspired this acquisition that will facilitate synergistic growth and expansion of services.”

Janet McDougall, Founder, McDougall Scientific, will retire following more than 35 years of operating Alimentiv Statistics. Janet will stay on as a consultant through the transition and offers the following: “Alimentiv Statistics has earned a reputation as an experienced CRO with a commitment to continually raising the standards of our industry. Valuable insights, timely, accurate data, and analytics leading to expedited time-to-market and lower development costs are the foundation of the work we do.”

Alimentiv and Alimentiv Statistics have core expertise in clinical trial design and statistical analysis. The combined strength of the organizations will provide benefits that include:
● Study design and statistical consulting services
● Data standards (CDISC), data conversion (SDTM/ADaM), and data
visualization services
● Observational, registry, real-world evidence study designs, and analyses
● Technology solutions for small biotech and virtual organizations including
EDC, IRT, and ComplyDocs (Alimentiv’s proprietary eTMF system)

Both companies are proud of their Canadian roots and support the continued growth of jobs in Canada and globally. Combined the companies have offices in London, ON; Toronto, ON; San Diego, USA; and Amsterdam, the Netherlands serving customers worldwide. Looking forward we expect to see strong continued growth in the global biostatics market and are excited about the benefits this acquisition brings and the opportunity we have to continue to prioritize our vision of building a leading clinical drug development CRO that through investment in academic research and delivery of clinical services accelerates drug discovery for our sponsors,” said Smith.

 

About Alimentiv Health Trust

Companies under the Alimentiv Health Trust are commercial ventures driven by the Evergreen principles of purpose, people first, and long-term profitable growth. Operating within the Trust allows the businesses the privilege to grow with a 100-year perspective, where the measure of success is not the value created by an exit, but rather the value created by fulfilling our purpose.

Alimentiv (CRO) is a global research organization providing clinical trials, central image management, and precision medicine services to the pharmaceutical and biotechnology industries. Headquartered in London Ontario, Alimentiv employs approximately 400 people across its operations in Canada, the United States, Europe, Asia-Pacific, and Latin America. Its unique model combines the efforts of leading, internationally recognized academic researchers with operational experts to offer integrated solutions to its customers. Founded in 1986 at the Robarts Research Institute, the clinical trials division was initially led by Dr. Henry Barnett.

In 1997, Dr. Brian Feagan, Professor of Medicine, Epidemiology & Biostatistics at Western University assumed leadership and built upon the foundation of academic excellence by focusing the organization on Inflammatory Bowel Disease (IBD) research. Over the past 20 years, Alimentiv has become recognized as an expert in clinical trial design, central image management solutions, outcome measure development, and precision medicine for drug development in IBD. Today, Alimentiv provides services in over 50 countries worldwide, collaborates with leading academic research institutions across the globe, and partners with many of the leading pharmaceutical and biotechnology organizations to bring new and improved treatment options to patients.

 

About Alimentiv Statistics

Alimentiv Statistics is a Clinical Research Organization (CRO) with renowned expertise in Clinical Trial Design, Statistical Analysis, and Data Management supporting clinical research. We provide trusted services to pharmaceutical, biotechnology & medical device companies in a variety of therapeutic areas across all phases of clinical trials. Our unique expertise along with the flexibility and
affordability of our services has helped make Alimentiv Statistics an integral and sought-after CRO for more than 35 years. We invite you to discover how we exceed the expectations of our clients: alimentivstatistics.com.

 

The official press release can be found here.